Table 1.
Table summarizing performance over different substitute CT approaches
Approach category | MRI sequence/contrast | Number | Site | Performance metric | Note | References | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
main | sub 1 | sub 2 | sub 3 | ΔDose [%] | MAE [HU] | DSC bone | Other | ||||||
Voxel | Semi-automatic | T1w | 20 | brain | 1 | ΔROI | [61] | ||||||
Threshold | dUTE | 1 | phantom | 2 | 0.81 | 87 | Cbone | [62–64] | |||||
dUTE | 5-19 | brain | 0.5 | 230 | 0.49-0.65 | 90 | Ctissue | [22, 35, 65] | |||||
Dixon | 2 | brain | 94/77 | SSbone | [66] | ||||||||
dUTE | Dixon | 6-98 | brain | 0.75 | 88/88,81 | SSbone, Ctissue | [67–69] | ||||||
Probabilistic | Clustering | Fuzzy c-means | T2w | Dixon | 2-5 | brain | 97-98/75-94 | SSbone | [70, 71] | ||||
T2w | T1w | 10 | brain | 98/74 | SSair | [52] | |||||||
dUTE | Dixon | 9 | brain | 130 | [72] | ||||||||
Bayesian | Markow RF | dUTE | 5 | brain | 1 | 204-247 | 0.53-0.59 | [22] | |||||
Regression | Discriminant | dUTE | T2w | 3 | phantom | 2.3 | 88 | [73] | |||||
dUTE | T2w | 3 | brain | 1.2 | 153 | [74] | |||||||
Gaussian | dUTE | T2w | 5-9 | brain | 0.9-1.5 | 137-140 | 0.85 | 68-94,98 | γ11, γ33 | [23, 75–77] | |||
dUTE | 5 | brain | 1 | 136-148 | 0.67-0.72 | [22, 48] | |||||||
Random F | dUTE | 5 | brain | 1 | 128 | 0.74 | [22] | ||||||
Semi-automatic Dual |
T1w | T2w | 9 | prostate | 0.7 | 75 | 0.91 | 99.9 | a, γ22 | [78] | |||
T1w | T2*w | 10-15 | prostate | 0.3-2 | 135 | 93 | γ11 | [21, 79, 80] | |||||
PCA | T1w | 10 | torso | 5 | Δbone | [81] | |||||||
Sinogram | T1w | 10 | brain | 0.85 | b | [82] | |||||||
Neural network | T1w | 3 | brain | 0.78 | [83] | ||||||||
dUTE | 4 | brain | 0.83 | [84] | |||||||||
Pattern recognition | dUTE | Dixon | 10 | brain | 76 | Cair | [85] | ||||||
Hybrid | Neural Network | Template | dUTE | 4 | brain | 0.77 | [86] | ||||||
Gaussian | Spatial info | dUTE | T2w | 9 | brain | 130 | [75] | ||||||
Random F | Spatial info | T1w | 9-10 | brain | 0.92-0.98 | c | [87, 88] | ||||||
Atlas | Pattern recognition | Patch Patch Probabilistic |
T1w | 5 40 |
brain | 0.5 | 85 | 0.84 0.75 |
[48] [89] |
||||
Deformable | T1w | 28 | whole body | 0.88 | DSCbrain | [90] | |||||||
T1w | T2w | 5-17 | brain | 1-2.5 | 97-114 | 0.63-0.83 | 1.7 | ΔROI | [24, 48, 91–94] | ||||
T2w | 37 | prostate | 1.5 | 0.79 | [25] | ||||||||
T2w | 10 | cervix | 0.3 | [95] | |||||||||
Hybrid | Deformable | Patch | T1w | 17 | brain | 101 | [96] | ||||||
T2w | 39 | Prostate | 0.3 | 40.5 | 0.91 | 100 | γ22 | [97] | |||||
Hybrid | Deformable | Probabilistic | T1w | 9-27 | brain | 126 | 0.86 | 86/90 | SSbone | [26, 98] | |||
T2w | 10 | prostate | 0.2 | 36.5 | 99.9 | γ21 | [27] | ||||||
Regression | Random F | T2w | 20 | prostate | 0.83 | DSCprostate | [99] | ||||||
Threshold | dUTE | 154 | brain | 0.81 | [100] |
Column 1: Overall approach: Voxel, atlas or hybrid. Column 2: Sub categories within each main approach. Column 3: MRI sequences/contrasts applied in the studies. Column 4: Number of subjects included in the studies (patients, volunteers, phantoms). Column 5: Anatomical site investigated. Column 6: Performance metrics. Column 7: Specification of “Other” metric and comments. Column 8: References to included studies. SSx = % specificity @ % sensitivity for tissue x, Cx = % correctly classified voxel for tissue x, Δx = mm distance bt. CT and sCT for tissue x, γxy = % of points with γx %ymm < 1 where x and y are the dosimetric and geometric deviations, respectively, aMAE of whole FOV and DSC based on 2D DRR, b Overlap ratio similar to DSCbone. c Bone > 600 HU. Method abbreviations: Bayesian Bayesian statistics, Markow RF Markow Random Fields, Discriminant Discriminant analysis, Random F Random Forest, PCA Principal Component Analysis, Patch = cluster/collection of MRI voxels, Deformable = deformable registration